125 related articles for article (PubMed ID: 11979462)
1. Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Sharathkumar A; Shaw PJ; Cooke-Yarborough C; Martin HC; Onikul E
Med Pediatr Oncol; 2002 May; 38(5):357-9. PubMed ID: 11979462
[No Abstract] [Full Text] [Related]
2. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
Riedinger JM; Eche N; Chevreau C; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
[TBL] [Abstract][Full Text] [Related]
3. A child with primary germ cell tumor of the liver.
Wang JD; Chou G; Yang CS; Shu SG; Chen HC; Chi CS; Chang TK
Acta Oncol; 2007; 46(8):1198-9. PubMed ID: 17978933
[No Abstract] [Full Text] [Related]
4. Testicular mixed germ cell tumor with polyembryoma component in brothers.
Bakaris S; Resim S; Tunali N
Pediatr Dev Pathol; 2005; 8(1):92-7. PubMed ID: 15803215
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy in nonseminomatous germ cell cancer.
Kollmannsberger C; Beyer J; Bokemeyer C
BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
[No Abstract] [Full Text] [Related]
7. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in management of patients with germ cell tumors and slight elevation of serum α-fetoprotein.
Albany C; Einhorn L
J Clin Oncol; 2014 Jul; 32(19):2114-5. PubMed ID: 24841979
[No Abstract] [Full Text] [Related]
10. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
[TBL] [Abstract][Full Text] [Related]
12. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
Gilbert DC; Norman AR; Nicholl J; Dearnaley DP; Horwich A; Huddart RA
BJU Int; 2006 Jul; 98(1):67-9. PubMed ID: 16831145
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
Einhorn LH; Foster RS
J Clin Oncol; 2006 Jun; 24(16):2597-8; author reply 2598-9. PubMed ID: 16735718
[No Abstract] [Full Text] [Related]
14. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
15. α-fetoprotein secreting extrapulmonary small-cell carcinoma of the liver.
Walshauser MA; Ishii K; Murugappan K; Masoom S; Yong S; Bhoopalam N
J Clin Oncol; 2013 Apr; 31(10):e152-4. PubMed ID: 23401444
[No Abstract] [Full Text] [Related]
16. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
17. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
[TBL] [Abstract][Full Text] [Related]
18. [Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy].
Riedinger JM; Eche N; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):515-21. PubMed ID: 18957340
[TBL] [Abstract][Full Text] [Related]
19. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
Kimura M; Onozawa M; Fujisaki A; Arakawa T; Takeda K; Dalmau J; Hattori K
Int J Urol; 2008 Oct; 15(10):942-3. PubMed ID: 19138287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]